test

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors

Conditions

Breast - Female | Colon | Esophagus | Rectum | Stomach

What is the purpose of this trial?

Dose finding, toxicity assessment

Participation Guidelines

Age:
Gender:

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale Cancer Center
Dates:
08/12/2012
Last Updated:
Study HIC#:
1112009424